At the outset of the pandemic, efficacy data for potential treatments were sparse and of low
quality. Despite the dynamic demands of the pandemic, it is remarkable how much our …

Viral clearance is likely the best way to assess the efficacy of antibody‐based therapies.
Although antibodies can mediate a variety of effects that include modulation of inflammation …

Background Monoclonal antibodies have gained attention in developing countries owing to
its benefits portrayed by few clinical trials. However, no studies until now have been …